Channel Therapeutics Corp

CHRO11 Dec 2024
Healthcare
$0.66
-0.12 (-12.24%)
Lowest Today
$0.58
Highest Today
$0.68
Today’s Open
$0.66
Prev. Close
$0.71
52 Week High
$6
52 Week Low
$0.45
To Invest in Channel Therapeutics Corp

Channel Therapeutics Corp

Healthcare
CHRO11 Dec 2024
-0.12 (-12.24%)
1M
3M
6M
1Y
5Y
Low
$0.58
Day’s Range
High
$0.68
0.58
52 Week Low
$0.45
52-Week Range
52 Week High
$6
0.45
1 Day
-
1 Week
-18.6%
1 month return
+26.87%
3 month return
-38.13%
6 month return
-55.47%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
5.34 mln
PB Ratio
4.11
PE Ratio
0
Enterprise Value
4.52 mln
Total Assets
0.1 mln
Volume

Fund house & investment objective

Company Information
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Organisation
Channel Therapeutics Corp
Employees
4
Industry
Biotechnology
CEO
Mr. Francis  Knuettel II, M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step